114 related articles for article (PubMed ID: 27088648)
1. Identification of Cyproheptadine as an Inhibitor of SET Domain Containing Lysine Methyltransferase 7/9 (Set7/9) That Regulates Estrogen-Dependent Transcription.
Takemoto Y; Ito A; Niwa H; Okamura M; Fujiwara T; Hirano T; Handa N; Umehara T; Sonoda T; Ogawa K; Tariq M; Nishino N; Dan S; Kagechika H; Yamori T; Yokoyama S; Yoshida M
J Med Chem; 2016 Apr; 59(8):3650-60. PubMed ID: 27088648
[TBL] [Abstract][Full Text] [Related]
2. Development of Novel Inhibitors for Histone Methyltransferase SET7/9 based on Cyproheptadine.
Hirano T; Fujiwara T; Niwa H; Hirano M; Ohira K; Okazaki Y; Sato S; Umehara T; Maemoto Y; Ito A; Yoshida M; Kagechika H
ChemMedChem; 2018 Aug; 13(15):1530-1540. PubMed ID: 29882380
[TBL] [Abstract][Full Text] [Related]
3. Steric structure-activity relationship of cyproheptadine derivatives as inhibitors of histone methyltransferase Set7/9.
Fujiwara T; Ohira K; Urushibara K; Ito A; Yoshida M; Kanai M; Tanatani A; Kagechika H; Hirano T
Bioorg Med Chem; 2016 Sep; 24(18):4318-4323. PubMed ID: 27448773
[TBL] [Abstract][Full Text] [Related]
4. Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase.
Subramanian K; Jia D; Kapoor-Vazirani P; Powell DR; Collins RE; Sharma D; Peng J; Cheng X; Vertino PM
Mol Cell; 2008 May; 30(3):336-47. PubMed ID: 18471979
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into estrogen receptor α methylation by histone methyltransferase SMYD2, a cellular event implicated in estrogen signaling regulation.
Jiang Y; Trescott L; Holcomb J; Zhang X; Brunzelle J; Sirinupong N; Shi X; Yang Z
J Mol Biol; 2014 Oct; 426(20):3413-25. PubMed ID: 24594358
[TBL] [Abstract][Full Text] [Related]
6. Identification and Characterizations of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Scaffold Hopping- and 2D-Molecular Fingerprint-Based Similarity Search.
Ding H; Lu WC; Hu JC; Liu YC; Zhang CH; Lian FL; Zhang NX; Meng FW; Luo C; Chen KX
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498708
[TBL] [Abstract][Full Text] [Related]
7. Role of SET7/9 in the progression of ischemic renal injury in diabetic and non-diabetic rats.
Sharma N; Sankrityayan H; Kale A; Gaikwad AB
Biochem Biophys Res Commun; 2020 Jul; 528(1):14-20. PubMed ID: 32448511
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of peptide-MCA substrates for a novel assay of histone methyltransferases and their inhibitors.
Chi H; Takemoto Y; Nsiama TK; Kato T; Nishino N; Ito A; Yoshida M
Bioorg Med Chem; 2014 Feb; 22(4):1268-75. PubMed ID: 24486204
[TBL] [Abstract][Full Text] [Related]
9. Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors.
Hou Z; Min W; Zhang R; Niu A; Li Y; Cao L; Han J; Luo C; Yang P; Ding H
Bioorg Med Chem Lett; 2020 May; 30(9):127061. PubMed ID: 32173197
[TBL] [Abstract][Full Text] [Related]
10. Structures of histone methyltransferase SET7/9 in complexes with adenosylmethionine derivatives.
Niwa H; Handa N; Tomabechi Y; Honda K; Toyama M; Ohsawa N; Shirouzu M; Kagechika H; Hirano T; Umehara T; Yokoyama S
Acta Crystallogr D Biol Crystallogr; 2013 Apr; 69(Pt 4):595-602. PubMed ID: 23519668
[TBL] [Abstract][Full Text] [Related]
11. Development of novel bisubstrate-type inhibitors of histone methyltransferase SET7/9.
Mori S; Iwase K; Iwanami N; Tanaka Y; Kagechika H; Hirano T
Bioorg Med Chem; 2010 Dec; 18(23):8158-66. PubMed ID: 21036620
[TBL] [Abstract][Full Text] [Related]
12. Computational discovery and biological evaluation of novel inhibitors targeting histone-lysine N-methyltransferase SET7.
Min W; Hou Z; Zhang F; Xie S; Yuan K; Dong H; Wang L; Qi L; Luo C; Ding H; Yang P
Bioorg Med Chem; 2020 Apr; 28(7):115372. PubMed ID: 32088124
[TBL] [Abstract][Full Text] [Related]
13. Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening.
Meng F; Cheng S; Ding H; Liu S; Liu Y; Zhu K; Chen S; Lu J; Xie Y; Li L; Liu R; Shi Z; Zhou Y; Liu YC; Zheng M; Jiang H; Lu W; Liu H; Luo C
J Med Chem; 2015 Oct; 58(20):8166-81. PubMed ID: 26390175
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer.
Zhang Y; Liu J; Lin J; Zhou L; Song Y; Wei B; Luo X; Chen Z; Chen Y; Xiong J; Xu X; Ding L; Ye Q
Oncotarget; 2016 Mar; 7(9):9859-75. PubMed ID: 26848522
[TBL] [Abstract][Full Text] [Related]
15. Non-histone Methylation of SET7/9 and its Biological Functions.
Gao L; Yu W; Song P; Li Q
Recent Pat Anticancer Drug Discov; 2022; 17(3):231-243. PubMed ID: 34856916
[TBL] [Abstract][Full Text] [Related]
16. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4.
Gauthier N; Caron M; Pedro L; Arcand M; Blouin J; Labonté A; Normand C; Paquet V; Rodenbrock A; Roy M; Rouleau N; Beaudet L; Padrós J; Rodriguez-Suarez R
J Biomol Screen; 2012 Jan; 17(1):49-58. PubMed ID: 21940714
[TBL] [Abstract][Full Text] [Related]
17. A direct label-free MALDI-TOF mass spectrometry based assay for the characterization of inhibitors of protein lysine methyltransferases.
Guitot K; Drujon T; Burlina F; Sagan S; Beaupierre S; Pamlard O; Dodd RH; Guillou C; Bolbach G; Sachon E; Guianvarc'h D
Anal Bioanal Chem; 2017 Jun; 409(15):3767-3777. PubMed ID: 28389916
[TBL] [Abstract][Full Text] [Related]
18. In silico discovery and validation of potent small-molecule inhibitors targeting the activation function 2 site of human oestrogen receptor α.
Singh K; Munuganti RS; Leblanc E; Lin YL; Leung E; Lallous N; Butler M; Cherkasov A; Rennie PS
Breast Cancer Res; 2015 Feb; 17(1):27. PubMed ID: 25848700
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of SET Domain-Containing Lysine Methyltransferase 7/9 Ameliorates Renal Fibrosis.
Sasaki K; Doi S; Nakashima A; Irifuku T; Yamada K; Kokoroishi K; Ueno T; Doi T; Hida E; Arihiro K; Kohno N; Masaki T
J Am Soc Nephrol; 2016 Jan; 27(1):203-15. PubMed ID: 26045091
[TBL] [Abstract][Full Text] [Related]
20. Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors.
Milite C; Feoli A; Viviano M; Rescigno D; Mai A; Castellano S; Sbardella G
ChemMedChem; 2016 Aug; 11(16):1680-5. PubMed ID: 27411844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
